Shura Robert D, Schroeder Ryan W, Ord Anna S, Bieu Rachel K, O'Connor Victoria L, Magnante Anna T, Snodgrass Makenna, Miskey Holly M, Martindale Sarah L, Rowland Jared A
W. G. (Bill) Hefner VA Healthcare System, Salisbury, NC, USA.
VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center, Durham, NC, USA.
Clin Neuropsychol. 2025 Oct;39(7):1960-1978. doi: 10.1080/13854046.2024.2432058. Epub 2024 Nov 22.
The present study sought to cross validate the recently developed total score cut-off for the Beck Depression Inventory-II (BDI-II) and identify additional embedded symptom validity indices within this commonly used self-report depression measure. Study 1 included a research sample of 379 veterans with diagnostic subgroups of Current and Lifetime Depression and Current and Lifetime Posttraumatic Stress Disorder (PTSD). Study 2 included a clinical sample of 224 veterans with diagnostic subgroups of Current Depression, Lifetime Depression, and No Depression. Three embedded BDI-II symptom validity indices were examined in the total samples and subgroups: the BDI-II Symptom Severity Scale (total raw score), BDI-II Extreme Symptom Scale (summed frequency of extreme responses), and the BDI-II Rare Items Scale (summed frequency of rarely endorsed items). Validity indices from the Personality Assessment Inventory were utilized in both studies, with the Miller Forensic Assessment of Symptoms Test also used in Study 1. In Study 1, BDI-II validity index cut-off scores had to be adjusted the highest for the Current Depression or Current PTSD subgroups. The cut-offs were associated with sensitivity rates ranging from 0.12 to 0.53 and specificity rates ranging from 0.90 to 0.96. In Study 2, cut-offs had to be adjusted, the highest for the Current Depression subgroup. Identified cut-offs had sensitivity rates ranging from 0.22 to 0.65 and specificity rates ranging from 0.89 to 0.95. This study supports the use of all three proposed BDI-II embedded symptom validity indices.
本研究旨在对最近制定的贝克抑郁量表第二版（BDI-II）总分临界值进行交叉验证，并在这一常用的自我报告抑郁测量工具中确定其他内在症状效度指标。研究1的样本为379名退伍军人，包括当前抑郁和终生抑郁以及当前和终生创伤后应激障碍（PTSD）的诊断亚组。研究2的临床样本为224名退伍军人，包括当前抑郁、终生抑郁和无抑郁的诊断亚组。在总样本和亚组中检验了BDI-II的三个内在症状效度指标：BDI-II症状严重程度量表（总原始分数）、BDI-II极端症状量表（极端反应的总频率）和BDI-II罕见项目量表（很少认可项目的总频率）。两项研究均使用了人格评估量表的效度指标，研究1还使用了米勒症状法医评估测试。在研究1中，BDI-II效度指标的临界值在当前抑郁或当前PTSD亚组中调整得最高。这些临界值的灵敏度率在0.12至0.53之间，特异度率在0.90至0.96之间。在研究2中，临界值也需要调整，在当前抑郁亚组中调整得最高。确定的临界值灵敏度率在0.22至0.65之间，特异度率在0.89至0.95之间。本研究支持使用所有三个提议的BDI-II内在症状效度指标。
